Advertisement
Screener

The Cigna Group (CI) Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest

2.8 / 5 stars · 54/98 Roast Me

The Cigna Group Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest

The Cigna Group (CI) reported Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest of $215.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.

Financial Statements › Income Statement › Net Income

us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest · last filed 2026-07-30

  • The Cigna Group net income (loss) attributable to nonredeemable noncontrolling interest for the quarter ending 2026-06-30 was $215.00M, a 115.00% increase year-over-year.
  • The Cigna Group net income (loss) attributable to nonredeemable noncontrolling interest for the quarter ending 2026-03-31 was $207.00M, a 140.70% increase year-over-year.
  • The Cigna Group net income (loss) attributable to nonredeemable noncontrolling interest for the quarter ending 2025-12-31 was $40.00M, a 64.29% decline year-over-year.
  • The Cigna Group net income (loss) attributable to nonredeemable noncontrolling interest for the quarter ending 2025-09-30 was $105.00M, a 22.09% increase year-over-year.
  • The Cigna Group net income (loss) attributable to nonredeemable noncontrolling interest for fiscal 2025 was $331.00M, a 3.78% decline from fiscal 2024.
  • The Cigna Group net income (loss) attributable to nonredeemable noncontrolling interest for fiscal 2024 was $344.00M, a 1128.57% increase from fiscal 2023.
  • The Cigna Group net income (loss) attributable to nonredeemable noncontrolling interest for fiscal 2023 was $28.00M, a 58.21% decline from fiscal 2022.
  • The Cigna Group net income (loss) attributable to nonredeemable noncontrolling interest for fiscal 2022 was $67.00M, a 116.13% increase from fiscal 2021.
Period endNet Income (Loss) Attributable to Nonredeemable Noncontrolling Interest 3 monthNet Income (Loss) Attributable to Nonredeemable Noncontrolling Interest 6 monthNet Income (Loss) Attributable to Nonredeemable Noncontrolling Interest 9 monthNet Income (Loss) Attributable to Nonredeemable Noncontrolling Interest 12 month
2026-06-30$215.00M
10-Q · filed 2026-07-30
$422.00M
10-Q · filed 2026-07-30
$462.00M
derived: sum of 3 quarters · filed 2026-07-30
$567.00M
derived: sum of 4 quarters · filed 2026-07-30
2026-03-31$207.00M
10-Q · filed 2026-04-30
$247.00M
derived: sum of 2 quarters · filed 2026-04-30
$352.00M
derived: sum of 3 quarters · filed 2026-04-30
$452.00M
derived: sum of 4 quarters · filed 2026-07-30
2025-12-31$40.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$145.00M
derived: sum of 2 quarters · filed 2026-02-26
$245.00M
derived: sum of 3 quarters · filed 2026-07-30
$331.00M
10-K · filed 2026-02-26
2025-09-30$105.00M
10-Q · filed 2025-10-30
$205.00M
derived: sum of 2 quarters · filed 2026-07-30
$291.00M
10-Q · filed 2025-10-30
$403.00M
derived: sum of 4 quarters · filed 2026-07-30
2025-06-30$100.00M
10-Q · filed 2026-07-30
$186.00M
10-Q · filed 2026-07-30
$298.00M
derived: sum of 3 quarters · filed 2026-07-30
$384.00M
derived: sum of 4 quarters · filed 2026-07-30
2025-03-31$86.00M
10-Q · filed 2026-04-30
$198.00M
derived: sum of 2 quarters · filed 2026-04-30
$284.00M
derived: sum of 3 quarters · filed 2026-04-30
$365.00M
derived: sum of 4 quarters · filed 2026-04-30
2024-12-31$112.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$198.00M
derived: sum of 2 quarters · filed 2026-02-26
$279.00M
derived: sum of 3 quarters · filed 2026-02-26
$344.00M
10-K · filed 2026-02-26
2024-09-30$86.00M
10-Q · filed 2025-10-30
$167.00M
derived: sum of 2 quarters · filed 2025-10-30
$232.00M
10-Q · filed 2025-10-30
$246.00M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30$81.00M
10-Q · filed 2025-07-31
$146.00M
10-Q · filed 2025-07-31
$160.00M
derived: sum of 3 quarters · filed 2026-02-26
$164.00M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31$65.00M
10-Q · filed 2025-05-02
$79.00M
derived: sum of 2 quarters · filed 2026-02-26
$83.00M
derived: sum of 3 quarters · filed 2026-02-26
$88.00M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31$14.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$18.00M
derived: sum of 2 quarters · filed 2026-02-26
$23.00M
derived: sum of 3 quarters · filed 2026-02-26
$28.00M
10-K · filed 2026-02-26
2023-09-30$4.00M
10-Q · filed 2024-10-31
$9.00M
derived: sum of 2 quarters · filed 2024-10-31
$14.00M
10-Q · filed 2024-10-31
$40.00M
derived: sum of 4 quarters · filed 2025-02-27
2023-06-30$5.00M
10-Q · filed 2024-08-01
$10.00M
10-Q · filed 2024-08-01
$36.00M
derived: sum of 3 quarters · filed 2025-02-27
$54.00M
derived: sum of 4 quarters · filed 2025-02-27
2023-03-31$5.00M
10-Q · filed 2024-05-02
$31.00M
derived: sum of 2 quarters · filed 2025-02-27
$49.00M
derived: sum of 3 quarters · filed 2025-02-27
$60.00M
derived: sum of 4 quarters · filed 2025-02-27
2022-12-31$26.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27
$44.00M
derived: sum of 2 quarters · filed 2025-02-27
$55.00M
derived: sum of 3 quarters · filed 2025-02-27
$67.00M
10-K · filed 2025-02-27
2022-09-30$18.00M
10-Q · filed 2023-11-02
$29.00M
derived: sum of 2 quarters · filed 2023-11-02
$41.00M
10-Q · filed 2023-11-02
$51.00M
derived: sum of 4 quarters · filed 2024-02-29
2022-06-30$11.00M
10-Q · filed 2023-08-03
$23.00M
10-Q · filed 2023-08-03
$33.00M
derived: sum of 3 quarters · filed 2024-02-29
$43.00M
derived: sum of 4 quarters · filed 2024-02-29
2022-03-31$12.00M
10-Q · filed 2023-05-05
$22.00M
derived: sum of 2 quarters · filed 2024-02-29
$32.00M
derived: sum of 3 quarters · filed 2024-02-29
$38.00M
derived: sum of 4 quarters · filed 2024-02-29
2021-12-31$10.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29
$20.00M
derived: sum of 2 quarters · filed 2024-02-29
$26.00M
derived: sum of 3 quarters · filed 2024-02-29
$31.00M
10-K · filed 2024-02-29
2021-09-30$10.00M
10-Q · filed 2022-11-03
$16.00M
derived: sum of 2 quarters · filed 2022-11-03
$21.00M
10-Q · filed 2022-11-03
$26.00M
derived: sum of 4 quarters · filed 2023-02-23
2021-06-30$6.00M
10-Q · filed 2022-08-04
$11.00M
10-Q · filed 2022-08-04
$16.00M
derived: sum of 3 quarters · filed 2023-02-23
$22.00M
derived: sum of 4 quarters · filed 2023-02-23
2021-03-31$5.00M
10-Q · filed 2022-05-06
$10.00M
derived: sum of 2 quarters · filed 2023-02-23
$16.00M
derived: sum of 3 quarters · filed 2023-02-23
$18.00M
derived: sum of 4 quarters · filed 2023-02-23
2020-12-31$5.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23
$11.00M
derived: sum of 2 quarters · filed 2023-02-23
$13.00M
derived: sum of 3 quarters · filed 2023-02-23
$17.00M
10-K · filed 2023-02-23
2020-09-30$6.00M
10-Q · filed 2021-11-04
$8.00M
derived: sum of 2 quarters · filed 2021-11-04
$12.00M
10-Q · filed 2021-11-04
$16.00M
derived: sum of 4 quarters · filed 2022-02-24
2020-06-30$2.00M
10-Q · filed 2021-08-05
$6.00M
10-Q · filed 2021-08-05
$10.00M
derived: sum of 3 quarters · filed 2022-02-24
$10.00M
derived: sum of 4 quarters · filed 2022-02-24
2020-03-31$4.00M
10-Q · filed 2021-05-07
$8.00M
derived: sum of 2 quarters · filed 2022-02-24
$8.00M
derived: sum of 3 quarters · filed 2022-02-24
$8.00M
derived: sum of 4 quarters · filed 2022-02-24
2019-12-31$4.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
$4.00M
derived: sum of 2 quarters · filed 2022-02-24
$4.00M
derived: sum of 3 quarters · filed 2022-02-24
$5.00M
10-K · filed 2022-02-24
2019-09-30$0.00
10-Q · filed 2020-11-05
$0.00
derived: sum of 2 quarters · filed 2020-11-05
$1.00M
10-Q · filed 2020-11-05
$1.00M
derived: sum of 4 quarters · filed 2021-02-25
2019-06-30$0.00
10-Q · filed 2020-08-06
$1.00M
10-Q · filed 2020-08-06
$1.00M
derived: sum of 3 quarters · filed 2021-02-25
$1.00M
derived: sum of 4 quarters · filed 2021-02-25
2019-03-31$1.00M
10-Q · filed 2020-05-07
$1.00M
derived: sum of 2 quarters · filed 2021-02-25
$1.00M
derived: sum of 3 quarters · filed 2021-02-25
$1.00M
derived: sum of 4 quarters · filed 2021-02-25
2018-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
$0.00
derived: sum of 2 quarters · filed 2021-02-25
$0.00
derived: sum of 3 quarters · filed 2021-02-25
$0.00
10-K · filed 2021-02-25
2018-09-30$0.00
10-Q · filed 2019-10-31
$0.00
derived: sum of 2 quarters · filed 2019-10-31
$0.00
10-Q · filed 2019-10-31
2018-06-30$0.00
10-Q · filed 2019-08-01
$0.00
10-Q · filed 2019-08-01
2018-03-31$0.00
10-Q · filed 2019-05-02
2017-12-31-$5.00M
10-K · filed 2020-02-27
2016-12-31-$17.00M
10-K · filed 2019-02-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
Elevance Health, Inc. (ELV)United States$86.364B16.90
HUMANA INC (HUM)United States$45.651B18.44
CENTENE CORP (CNC)United States$30.588B-6.22
MOLINA HEALTHCARE, INC. (MOH)United States$10.091B-1,697.50
Alignment Healthcare, Inc. (ALHC)United States$1.593B121.28
TRUPANION, INC. (TRUP)United States$0.984B
UNITEDHEALTH GROUP INC (UNH)United States$336.652B26.62